Development of coincidence biodetectors

先进的研究技术已经被用来表明，有可能提取关于药物目标和目标药物反应的详细信息。目前，在常规的临床环境中获得这种信息是不现实的。这里的提议旨在举例说明一种新技术，该技术最终将满足临床对此类信息的需求。预计即将开发的技术的普遍使用将对诊断学在临床决策中的应用产生广泛影响。关键的贡献将是定义哪些患者应该接受哪些药物-个性化药物议程。

Sophisticated research techniques have been used to show that it is possible to extract detailed information about the targets of drugs and target responses to drugs. At present, achieving this sort of information in a routine clinical setting is not practical. The proposal here is designed to exemplify a new technology that will ultimately satisfy the clinical need for this type of information. It is anticipated that the general use of the technology to be developed will impact broadly on the application of diagnostics to clinical decision making. The key contribution will be to defining which patients should receive which drugs - the personalised medicine agenda.